Connect with us

Hi, what are you looking for?


Molnopiravir. The COVID-19 drug has been approved for use in Japan

Molnopiravir.  The COVID-19 drug has been approved for use in Japan

Kyodo reported that the government in Tokyo signed a contract with the drug manufacturer for a total of 1.6 million doses.

Clinical trials of the Japanese subsidiary of Merck & Co. He showed that medication given to patients within five days of developing symptoms of COVID-19 drops by 30%. The risk of hospitalization or death associated with the disease.

Outside of Japan, Molnopiravir was approved for use in Great Britain in November. In the United States, the Food and Drug Administration (FDA) gave emergency approval Thursday. The day before, the same institution issued a similar permit for another coronavirus drug, Baxlovid, which is manufactured by Pfizer. Kyodo said the drug company will deliver 2 million doses of the drug to Japan, but so far it has not been authorized for use in that country.

See also  Spain: smashing the largest heroin gang
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


Another person familiar with Sony’s plans confirms the killer news for PS5 owners. Horizon Forbidden West is not expected to appear on the market...


Farmer reveals government plans for CPK The farmer who issued the documents is a member of the social council of the CPK. As he...


Cybercriminals attacked the European branch of Media Markt. We still shop in the store, although some services are not working. How to protect yourself...


It has always been said that the iPhone 14 Pro will be deprived of the distinctive notch in the screen in favor of a...